Researchers at Arizona State University are experimenting with a compound that might prevent Alzheimer’s and other neurodegenerative diseases, such as Parkinson’s disease, and potentially Down syndrome.
Gene testing company Illumina won a jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a Roche subsidiary, of using patented prenatal testing technology without authorization.
Drug developer Transition Therapeutics Inc said its experimental drug reduced severe agitation and aggression in Alzheimer’s patients, citing data from a large study. The company said on Thursday that it would use the data to discuss a potential late-stage trial of the drug, ELND005, with the U.S. Food and Drug Administration. The company said in […]